Combined Chloroquine/Fansidar®-Resistant Falciparum Malaria Appears in East Africa

Urs HessKilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Urs Hess in
Current site
Google Scholar
PubMed
Close
,
Peter Maarten TimmermansKilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Peter Maarten Timmermans in
Current site
Google Scholar
PubMed
Close
, and
Michael JonesKilimanjaro Christian Medical Centre, Tanzania Consultant Hospital, Moshi, Tanzania, East Africa

Search for other papers by Michael Jones in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

The first two cases from East Africa of RII chloroquine- and Fansidar®-resistant falciparum malaria are described. The first case occurred in a non-immune Swedish expatriate 2 weeks after arrival in Tanzania, and the second in a semi-immune Tanzanian soldier. Fansidar has not yet been marketed in Tanzania. The significance and etiology of the occurrence of combined chloroquine/Fansidar resistance in East Africa are discussed.

Author Notes

Present address: % Internal Department, Elisabeth's Gasthuis, Boerhaavelaan 22, 2035 RC Haarlem, The Netherlands.

Save